Your browser doesn't support javascript.
loading
Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics.
Wachter, Stefanie; Angevin, Thibaut; Bubna, Niket; Tan, Adelene; Cichy, Adam; Brown, David; Wolfe, Leslie S; Sappington, Ryan; Lilla, Edward; Berry, Luke; Grismer, Dane; Orth, Christian; Blanusa, Milan; Mostafa, Sigma; Kaufmann, Hitto; Felderer, Karin.
Afiliação
  • Wachter S; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany. Electronic address: stefaniemwachter@gmail.com.
  • Angevin T; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Bubna N; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Tan A; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Cichy A; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Brown D; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Wolfe LS; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Sappington R; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Lilla E; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Berry L; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Grismer D; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Orth C; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Blanusa M; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Mostafa S; KBI Biopharma, 4117 Emperor Blvd, Suite 200, Durham, NC 27703, USA.
  • Kaufmann H; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
  • Felderer K; Pieris Pharmaceuticals GmbH, Zeppelinstr. 3, Hallbergmoos 85399 Germany.
J Biotechnol ; 377: 13-22, 2023 Nov 20.
Article em En | MEDLINE | ID: mdl-37820750
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reatores Biológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reatores Biológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article